NEW YORK--(BUSINESS WIRE)--May 3, 2006--FermaVir Pharmaceuticals, Inc. (OTCBB:FMVR - News) is pleased to announce that four abstracts on its research and development on compounds for the treatment of shingles have been accepted for presentation at the 19th International Conference on Antiviral Research to be held in San Juan, Puerto Rico May 7th-11th, 2006. The work to be presented is a three-way collaboration between the company, Cardiff University, Cardiff, Wales and the Rega Institute of the Katholieke Universiteit, Leuven, Belgium.
